bpc-157 fda warning 2024 2025 FDA's Overreach on Compounded Peptides BPC-157 Legal Status: FDA Regulations
Description
Scientists don't yet know why
In mice at thermoneutrality, repeated dosing increases energy expenditure, lowers RER, reduces fat mass and adipocyte size, and improves hepatic lipid metrics
PMID: 17576904
Supportive Care: Combine with IV therapy, nutrition planning, or exercise guidance for enhanced outcomes
Individual response varies significantly based on body weight, metabolic factors, and the specific condition being addressed
